Evidence map›Paper›PMID 31988640›Full record

ReviewCellular & molecular biology letters2020

DNA-dependent protein kinase in telomere maintenance and protection.

Jiangdong Sui, Shichuan Zhang, Benjamin P C Chen

Open access · goldAbstract readReview
In one paragraph

Review in Cellular & molecular biology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Secrets of DNA-PKcs beyond DNA repair.NPJ precision oncology · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Jiangdong Sui1Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, 400030 China.ORCID 0000-0001-5171-1978
Shichuan Zhang2Department of Radiation Oncology, Sichuan Cancer Hospital, Chengdu, China.
Benjamin P C Chen3Department of Radiation Oncology, University of Texas Southwestern Medical Center, 2201 Inwood Rd., Dallas, TX 75390-9187 USA.
Chongqing University · CNSichuan Cancer Hospital · CNThe University of Texas Southwestern Medical Center · US

Funding

DNA-PKcs and PIDD interaction in DNA damage responseR01CA233594 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI DAVIS, ANTHONY J · 2019 to 2023
$1.8M
NCI NIH HHS R01 CA233594
6 · The paper itself

Abstract

This review focuses on DNA-dependent protein kinase (DNA-PK), which is the key regulator of canonical non-homologous end-joining (NHEJ), the predominant mechanism of DNA double-strand break (DSB) repair in mammals. DNA-PK consists of the DNA-binding Ku70/80 heterodimer and the catalytic subunit DNA-PKcs. They assemble at DNA ends, forming the active DNA-PK complex, which initiates NHEJ-mediated DSB repair. Paradoxically, both Ku and DNA-PKcs are associated with telomeres, and they play crucial roles in protecting the telomere against fusions. Herein, we discuss possible mechanisms and contributions of Ku and DNA-PKcs in telomere regulation.

Indexed as

AnimalsDNA-Activated Protein KinaseDNA End-Joining RepairDNA Topoisomerases, Type IIHeterogeneous Nuclear Ribonucleoprotein A1HumansKu AutoantigenShelterin ComplexTelomeraseTelomereTelomere-Binding ProteinsDNA-Activated Protein KinaseDNA Topoisomerases, Type IIHeterogeneous Nuclear Ribonucleoprotein A1Ku AutoantigenShelterin ComplexTelomeraseTelomere-Binding ProteinsDNA–PKhnRNP–A1ShelterinTelomeraseTelomere

Identifiers

PMID31988640
PMCPMC6969447
OpenAlexW3003758510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.